Cancer - Big Pharma want to drain you of cash before you die

Avastin, $5,000/month; Zaltrap, $11,000/month; Yervoy, $39,000/month; Provenge, $93,000/course of treatment; Erbitux, $8,400/month; Gleevec, $92,000/year; Tasigna, $115,000/year; Sprycel, $123,000/year.

(Photo: Illustrations by Remie Geoffroi)

http://nymag.com/news/features/cancer-drugs-2013-10/#!